Camurus Annual Report for 2017
Lund — 22 March 2018 — Camurus (CAMX) today announces that the Annual Report for 2017 now is available at the company’s website: www.camurus.com. About CamurusCamurus is a Swedish research-based pharmaceutical company committed to developing and commercialising innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the proprietary FluidCrystal® drug delivery technologies and an extensive R&D expertise. Camurus’ clinical pipeline includes products for treatment of cancer, endocrine